Oral valganciclovir treatment for congenital cytomegalovirus infection

Pediatr Int. 2011 Apr;53(2):249-52. doi: 10.1111/j.1442-200X.2010.03217.x.

Authors

Takashi Imamura¹, Tatsuo Suzutani, Hiroshi Ogawa, Kimisato Asano, Mika Nomoto, Takamichi Matsui, Nobuo Momoi, Kazufumi Ikuta, Naoki Inoue, Mitsuaki Hosoya

Affiliation

¹ Departments of PediatricsMicrobiologyOtolaryngologyObstetrics, Fukushima Medical University School of Medicine, FukushimaDepartment of Virology I, National Institute of Infectious Diseases, Tokyo, Japan. ima@fmu.ac.jp

PMID: 21501311
DOI: 10.1111/j.1442-200X.2010.03217.x

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Administration, Oral
Adult
Antiviral Agents / administration & dosage
Antiviral Agents / therapeutic use*
Audiometry
Cytomegalovirus Infections / diagnosis
Cytomegalovirus Infections / drug therapy*
Disease Progression
Female
Ganciclovir / administration & dosage
Ganciclovir / analogs & derivatives*
Ganciclovir / therapeutic use
Hearing Loss / virology*
Humans
Infant
Infant, Newborn
Neonatal Screening
Pregnancy
Pregnancy Complications, Infectious / drug therapy*
Valganciclovir

Substances

Antiviral Agents
Valganciclovir
Ganciclovir